These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19592461)

  • 21. Upregulation of lung soluble guanylate cyclase during chronic hypoxia is prevented by deletion of eNOS.
    Li D; Laubach VE; Johns RA
    Am J Physiol Lung Cell Mol Physiol; 2001 Aug; 281(2):L369-76. PubMed ID: 11435211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASIC1-mediated calcium entry stimulates NFATc3 nuclear translocation via PICK1 coupling in pulmonary arterial smooth muscle cells.
    Gonzalez Bosc LV; Plomaritas DR; Herbert LM; Giermakowska W; Browning C; Jernigan NL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L48-58. PubMed ID: 27190058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble guanylate cyclase modulates alveolarization in the newborn lung.
    Bachiller PR; Cornog KH; Kato R; Buys ES; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L569-81. PubMed ID: 23934926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NFATc3 pathway participates in the process that 15-LO/15-HETE protects pulmonary artery smooth muscle cells against apoptosis during hypoxia.
    Ran Y; Wu H; Wei L; Yu X; Chen J; Li S; Zhang L; Lou J; Zhu D
    J Recept Signal Transduct Res; 2014 Aug; 34(4):270-82. PubMed ID: 24853029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.
    Weissmann N; Hackemack S; Dahal BK; Pullamsetti SS; Savai R; Mittal M; Fuchs B; Medebach T; Dumitrascu R; Eickels Mv; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L658-65. PubMed ID: 19617308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase G phosphorylates soluble guanylyl cyclase on serine 64 and inhibits its activity.
    Zhou Z; Sayed N; Pyriochou A; Roussos C; Fulton D; Beuve A; Papapetropoulos A
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1803-10. PubMed ID: 18635821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
    Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide.
    Ye L; Liu J; Liu H; Ying L; Dou D; Chen Z; Xu X; Raj JU; Gao Y
    Pflugers Arch; 2013 Feb; 465(2):333-41. PubMed ID: 23143201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of integrin-linked kinase in the hypoxia-induced phenotypic transition of pulmonary artery smooth muscle cells: Implications for hypoxic pulmonary hypertension.
    Hou J; Liu B; Zhu B; Wang D; Qiao Y; Luo E; Nawabi AQ; Yan G; Tang C
    Exp Cell Res; 2019 Sep; 382(2):111476. PubMed ID: 31255599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NO-independent activators of soluble guanylate cyclase: therapeutic potential.
    Mathew R
    Am J Hypertens; 2009 May; 22(5):470. PubMed ID: 19387430
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitric oxide receptor soluble guanylyl cyclase undergoes splicing regulation in differentiating human embryonic cells.
    Sharin VG; Mujoo K; Kots AY; Martin E; Murad F; Sharina IG
    Stem Cells Dev; 2011 Jul; 20(7):1287-93. PubMed ID: 20964618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.
    de Frutos S; Caldwell E; Nitta CH; Kanagy NL; Wang J; Wang W; Walker MK; Gonzalez Bosc LV
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H356-63. PubMed ID: 20495147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
    El-Awady MS; Smirnov SV; Watson ML
    Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.
    Sharina IG; Cote GJ; Martin E; Doursout MF; Murad F
    Nitric Oxide; 2011 Oct; 25(3):265-74. PubMed ID: 21867767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFATc3 regulation of collagen V expression contributes to cellular immunity to collagen type V and hypoxic pulmonary hypertension.
    Sheak JR; Jones DT; Lantz BJ; Maston LD; Vigil D; Resta TC; Resta MM; Howard TA; Kanagy NL; Guo Y; Jankowska-Gan E; Sullivan JA; Braun RK; Burlingham WJ; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L968-L980. PubMed ID: 32997513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFATc3 is required for intermittent hypoxia-induced hypertension.
    de Frutos S; Duling L; Alò D; Berry T; Jackson-Weaver O; Walker M; Kanagy N; González Bosc L
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2382-90. PubMed ID: 18359899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dissection of mouse soluble guanylyl cyclase alpha1 promoter.
    Vazquez-Padron RI; Pham SM; Pang M; Li S; Aïtouche A
    Biochem Biophys Res Commun; 2004 Jan; 314(1):208-14. PubMed ID: 14715267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
    Dumitrascu R; Weissmann N; Ghofrani HA; Dony E; Beuerlein K; Schmidt H; Stasch JP; Gnoth MJ; Seeger W; Grimminger F; Schermuly RT
    Circulation; 2006 Jan; 113(2):286-95. PubMed ID: 16391154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
    Szema AM; Forsyth E; Ying B; Hamidi SA; Chen JJ; Hwang S; Li JC; Sabatini Dwyer D; Ramiro-Diaz JM; Giermakowska W; Gonzalez Bosc LV
    PLoS One; 2017; 12(1):e0170606. PubMed ID: 28125639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.